T R A C K P A P E R 
Volume 17 Issue 6
Home
| S.No. | Title & Authors | Page No | View | ||
| 1 |
Title : A Smart Drug Dispensing Solution & Management System with Arduino Authors : Vipra Bohara, Lokesh Sharma, Rakesh Kardam, Ram Singh, Gopal Tiwari, Neeraj Kumawat
Abstract :
As technology advances, it becomes more and more clear that streamlined processes are demanded across a range of diligence. An automated medicine dispenser that's intended to fully transfigure drug administration is also oven result that's presented in this abstract. In contrast to conventional allocating ways, this system effectively automates the allocating process by exercising state- of- the- art technologies. Cases admit accurate drug delivery thanks to the automatic medicine dispenser, which reduces mortal error and improves perfection. This abstract emphasizes the value of technological invention in healthcare and stresses how automated results can enhance patient issues and expedite executive processes in the field. |
01-04 |
|
||
| 2 |
Title : Recurrent Venous Thrombosis in a Flight Attendant
Authors : Meryem Zerrik, Houda Echchachoui, Mouna El ghazi, Fahd Bennani Smiress, Zakaria Iloughmane, El khalifasidi Mohamed, Tlemcani Fatima Zahra, Mohamed Chemsi
Abstract :
Deep vein thrombosis (DVT) is a common pathology with an estimated incidence of 1.2 per million inhabitants in France, but this figure is probably underestimated. In the aviation environment, many factors can influence the physiopathology and cause VTE. This condition threatens flight safety due to the risk of embolism and poses a problem for the assessment of fitness, its treatment, and its functional consequences. Using a case of recurrent VTE in a flight attendant, we will review the pathophysiology of VTE, and the relationship between VTE and its treatment in the aviation environment. We will also review international aeromedical regulatory guidelines and aeromedical certification in the case of VTE. |
05-06 |
|
||
| 3 |
Title : Complete Response To Enzalutamide In A Patient With Metastatic Hormone-Sensitive Prostate Cancer : What About Therapeutic De-Escalation?
Authors : Choukri Elm’hadi, Meryem Zerrik, Mohammed Amine Saad, Yassir Benameur , Rachid Tanz
Abstract :
Androgen receptor pathway inhibitors (ARPIs) with or without docetaxel have revolutionised the treatment of metastatic castrate-sensitive prostate cancer.Case presentation: A 78-year-old patient with low-volume de no vo metastatic prostate cancer was started on enzalutamide at a dose of 160 mg per day along with triptoreline every three months. Within 6 months, the patient achieved a complete prostate-specific antigen response. Follow-up 18F-fluorocholine positron emission tomography showed no area of pathological metabolic activity. Treatment was well tolerated over 36 months.Conclusion: Complete response to ARPI is an emerging situation that deserves further consideration. |
07-10 |
|
